Abstract
To investigate prenatal and postnatal outcomes of atrial flutter and its association with the development of a second tachycardia, following restoration of sinus rhythm, in the fetus or newborn. This study is a retrospective review of all fetuses that presented with atrial flutter from January 2001 to December 2019 at the University Hospital of Wales, Cardiff, UK. The specific type of arrhythmia, its time of appearance and clinical characteristics, echocardiographic findings, medical management, and postnatal outcomes were evaluated. Sixteen fetuses were diagnosed with atrial flutter (AFL). Thirteen fetuses had persistent AFL and three fetuses had intermittent AFL. Seven patients had hydrops, of which one had Ebstein’s anomaly and the other six had normal hearts. Three of the fetuses that presented with AFL were diagnosed at 20, 21, and 23 weeks’ gestation and the remainder were diagnosed in the third trimester. Thirteen patients with AFL received antiarrhythmic drugs and three were delivered without any treatment. Five fetuses with AFL developed atrioventricular reciprocating tachycardia following DC cardioversion after birth, and four of them exhibited pre-excitation on the ECG. These five patients (31.3%) required postnatal antiarrhythmic treatment for up to 2 years. Pre-excitation disappeared in two patients during follow-up and two asymptomatic patients with neonatal pre-excitation required accessory pathway ablation. Fetal atrial flutter has a strong association with atrioventricular reciprocating tachycardia and ventricular pre-excitation in the neonatal period. Therefore, electrocardiograms should be carefully reviewed in newborns following the initial resolution of atrial flutter.
Similar content being viewed by others
References
Oudijk MA, Ruskamp JM, Ververs FF, Ambachtsheer EB, Stoutenbeek P, Visser GH, Meijboom EJ (2003) Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol 42:765–770
Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U (2003) Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89:913–917
Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, McCrindle BW, Ryan G, Manlhiot C, Blom NA (2011) Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 124:1747–1754
van Engelen AD, Weijtens O, Brenner JI, Kleinman CS, Copel JA, Stoutenbeek P, Meijboom EJ (1994) Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 24:1371–1375
Naheed ZJ, Strasburger JF, Deal BJ, Benson DW Jr, Gidding SS (1996) Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 27:1736–1740
Strasburger JF, Cuneo BF, Michon MM, Gotteiner NL, Deal BJ, McGregor SN, Oudijk MA, Meijboom EJ, Feinkind L, Hussey M, Parilla BV (2004) Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 109:375–379
DeVore GR (2005) Assessing fetal cardiac ventricular function. Semin Fetal Neonatal Med 10:515–541
Jaeggi E, Fouron JC, Drblik SP (1998) Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. J Pediatr 132:335–339
Simpson JM, Sharland GK (1998) Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 79:576–581
Till J, Wren C (1992) Atrial flutter in the fetus and young infant: an association with accessory connections. Br Heart J 67:80–83
Fujimura O, Klein GJ, Yee R, Sharma AD (1990) Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway? J Am Coll Cardiol 15:1082–1086
Wacker-Gussmann A, Strasburger JF, Srinivasan S, Cuneo BF, Lutter W, Wakai RT (2016) Fetal atrial flutter: electrophysiology and associations with rhythms involving an accessory pathway. J Am Heart Assoc 5:6
O'Leary ET, Alexander ME, Bezzerides VJ, Drogosz M, Economy KE, Friedman KG, Pickard SS, Tworetzky W, Mah DY (2020) Low mortality in fetal supraventricular tachycardia: outcomes in a 30-year single-institution experience. J Cardiovasc Electrophysiol 31:1105–1113
Hahurij ND, Blom NA, Lopriore E, Aziz MI, Nagel HT, Rozendaal L, Vandenbussche FP (2011) Perinatal management and long-term cardiac outcome in fetal arrhythmia. Early Hum Dev 87:83–87
Lisowski LA, Verheijen PM, Benatar AA, Soyeur DJ, Stoutenbeek P, Brenner JI, Kleinman CS, Meijboom EJ (2000) Atrial flutter in the perinatal age group: diagnosis, management and outcome. J Am Coll Cardiol 35:771–777
Miyoshi T, Maeno Y, Sago H, Inamura N, Yasukochi S, Kawataki M, Horigome H, Yoda H, Taketazu M, Shozu M, Nii M, Hagiwara A, Kato H, Shimizu W, Shiraishi I, Sakaguchi H, Ueda K, Katsuragi S, Ikeda T, Yamamoto H, Hamasaki T (2017) Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial. BMJ Open 7:e016597
Lulić Jurjević R, Podnar T, Vesel S (2009) Diagnosis, clinical features, management, and post-natal follow-up of fetal tachycardias. Cardiol Young 19:486–493
Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J (1995) The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenat Diagn 15:1297–1302
Ebenroth ES, Cordes TM, Darragh RK (2001) Second-line treatment of fetal supraventricular tachycardia using flecainide acetate. Pediatr Cardiol 22:483–487
Cunningham T, Uzun O, Morris R, Franciosi S, Wong A, Jeremiasen I, Sherwin E, Sanatani S (2017) The safety and effectiveness of flecainide in children in the current era. Pediatr Cardiol 38:1633–1638
Aliot E, Capucci A, Crijns HJ, Goette A, Tamargo J (2011) Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Europace 13:161–173
Uzun O, Babaoglu K, Sinha A, Massias S, Beattie B (2012) Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Cardiol Young 22:372–380
Zielinsky P, Dillenburg RF, de Lima GG, Zimmer LP (1998) Fetal supraventricular tachyarrhythmias. Experience of a fetal cardiology referral center. Arq Bras Cardiol 70:337–340
Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U (2002) Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 19:158–164
Dunnigan A, Benson W Jr, Benditt DG (1985) Atrial flutter in infancy: diagnosis, clinical features, and treatment. Pediatrics 75:725–729
Hinkle KA, Peyvandi S, Stiver C, Killen SAS, Weng HY, Etheridge SP, Puchalski MD (2017) Postnatal outcomes of fetal supraventricular tachycardia: a multicenter study. Pediatr Cardiol 38:1317–1323
Moodley S, Sanatani S, Potts JE, Sandor GG (2013) Postnatal outcome in patients with fetal tachycardia. Pediatr Cardiol 34:81–87
Mazur A, Meisel S, Shotan A, Strasberg B (2005) The mechanism of sudden death in the Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 16:1393
Acknowledgements
We would like to thank all the midwives, nurses, ultrasonographers, radiologists, obstetricians, adult cardiologists, neonatologists, and pediatricians for their help and involvement in the management and follow-up of these patients.
Funding
The authors received no financial support for the research and/or authorship of this article.
Author information
Authors and Affiliations
Contributions
OU had primary responsibility of the data collections, analysis of the results. GT and OU equally contributed to the paper in all stages by systematically organizing the data, critically appraising and writing of the manuscript. ML critically appraised and edited the paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Ethical Approval
Since the data were collected as part of routine clinical work and completely anonymized prior to retrospective analysis, a specific ethical approval application was not considered necessary. All procedures relating to this review were carried out in accordance with the Declaration of Helsinki.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tunca Sahin, G., Lewis, M. & Uzun, O. Association of Fetal Atrial Flutter with Neonatal Atrioventricular Re-entry Tachycardia Involving Accessory Pathway: A Link to be Remembered. Pediatr Cardiol 42, 849–856 (2021). https://doi.org/10.1007/s00246-021-02549-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-021-02549-6